Published in Hepatitis Weekly, May 7th, 2001
Patients with unresectable stage IV-A hepatocellular carcinoma have relatively few chemotherapeutic treatment options. However, researchers in Japan now say that enteric-coated tegafur/uracil could significantly prolong survival for a number of these patients.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.